AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2019
Apr 10, 2019
33298_dirs_2019-04-10_9d585607-3090-48d6-bba4-f63e333f89bb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: CONVERSION LABS, INC. (CVLB)
CIK: 0000948320
Period of Report: 2019-04-01
Reporting Person: Pineiro Dagnery Juan Manuel (Chief Financial Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, par value $0.01 | 200000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option to purchase Common Stock | $0.20 | 2026-07-01 | Common Stock (50000) | Direct | |
| Option to purchase Common Stock | $0.40 | 2026-07-01 | Common Stock (75000) | Direct |
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17